ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 585,80
-0,61%
Dow Jones
40 211,72
0,53%
DAX
18 511,90
-0,47%
Brent Oil
83,655
-0,81%
Bitcoin
63 249,71
-2,47%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
04/08/201609h03Dow Jones NewsBusiness Watch -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
03/08/201615h21Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NYSE:TEVATeva Pharmaceutical Industries Ltd
03/08/201614h40Dow Jones NewsTeva to Buy Generics Distributor Anda From Allergan for $500 MillionNYSE:TEVATeva Pharmaceutical Industries Ltd
03/08/201613h11Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
03/08/201613h00Business WireTeva Announces Acquisition of Anda Inc.NYSE:TEVATeva Pharmaceutical Industries Ltd
03/08/201609h03Dow Jones NewsIn Quest to Grow, Rivals Woo Biogen -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
03/08/201601h59Dow Jones NewsBiogen Draws Takeover Interest from Rival Drugmakers--2nd UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
02/08/201621h30Dow Jones NewsBiogen Attracts Takeover Interest From Two RivalsNYSE:TEVATeva Pharmaceutical Industries Ltd
02/08/201621h22Dow Jones NewsBiogen Draws Takeover Interest from Rival Drugmakers--UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
02/08/201621h12Dow Jones NewsBiogen Draws Takeover Interest from Rival DrugmakersNYSE:TEVATeva Pharmaceutical Industries Ltd
02/08/201620h06PR Newswire (US)Teva Completes Acquisition of Actavis GenericsNYSE:TEVATeva Pharmaceutical Industries Ltd
02/08/201617h10Business WireCORRECTING & REPLACING Teva Pharmaceuticals Initiates Voluntary Nationwide Recall of Seven Lots of Amikacin Sulfate Injection...NYSE:TEVATeva Pharmaceutical Industries Ltd
29/07/201615h00Business WireTeva Pharmaceuticals Initiates Voluntary Nationwide Recall of Seven Lots of Amikacin Sulfate Injection USP 500mg/2 mL (250 mg...NYSE:TEVATeva Pharmaceutical Industries Ltd
28/07/201615h42Dow Jones NewsU.S. Hot Stocks: Hot Stocks to WatchNYSE:TEVATeva Pharmaceutical Industries Ltd
28/07/201609h03Dow Jones NewsFacebook Rides Mobile-Ad Surge -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
28/07/201602h00Dow Jones NewsFacebook Posts Strong Profit and Revenue Growth--UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
28/07/201601h41Dow Jones NewsCorrection to Teva, Allergan ArticleNYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/201622h50Dow Jones NewsFacebook Posts Strong Profit and Revenue GrowthNYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/201622h01Business WireTeva to Report Second Quarter 2016 Financial Results on August 4, 2016NYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/201622h00Dow Jones NewsTeva, Allergan Get FTC Approval for Generics PurchaseNYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/201620h36Business WireTeva Receives Clearance from the U.S. Federal Trade Commission for Actavis Generics AcquisitionNYSE:TEVATeva Pharmaceutical Industries Ltd
21/07/201620h52Business WireTeva Announces Pricing of Additional CHF1.0 Billion of Senior Notes in Connection with Pending Acquisition of Actavis GenericsNYSE:TEVATeva Pharmaceutical Industries Ltd
20/07/201622h03Business WireTeva Announces Pricing of Additional €4.0 Billion of Senior Notes in Connection with Pending Acquisition of Actavis GenericsNYSE:TEVATeva Pharmaceutical Industries Ltd
19/07/201623h18Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NYSE:TEVATeva Pharmaceutical Industries Ltd
19/07/201612h05Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NYSE:TEVATeva Pharmaceutical Industries Ltd
19/07/201603h17Business WireTeva Announces Pricing of $15 Billion of Senior Notes in Connection with Pending Acquisition of Actavis GenericsNYSE:TEVATeva Pharmaceutical Industries Ltd
19/07/201600h11Dow Jones NewsTeva Sells $15 Billion of BondsNYSE:TEVATeva Pharmaceutical Industries Ltd
18/07/201623h46Dow Jones NewsADRs End Higher; ARM Holdings SoarsNYSE:TEVATeva Pharmaceutical Industries Ltd
18/07/201621h03Dow Jones NewsTeva Finalizes Bond Sale -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
18/07/201620h10Dow Jones NewsTeva Finalizes Bond SaleNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

EU
AI
Air Liquide
NASDAQ
AAPL
Apple
EU
PX1
CAC 40
EU
VIV
Vivendi
EU
BNP
BNP Paribas
NASDAQ
GOOGL
Alphabet
FTSE
UKX
FTSE 100
COIN
BTCUSD
Bitcoin
NYSE
NKE
Nike
EU
HO
Thales
EU
AF
Air FranceKLM
EU
PX4
SBF 120
EU
EN
Bouygues
EU
MC
Lvmh Moet Hennessy Louis...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés